Paul Tudor Jones Bluebird Bio, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 43,795 shares of BLUE stock, worth $18,393. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,795

Previous 107,960 59.43%

Holding current value

$18,393

Previous $105,000 79.05%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.47 - $1.35 $30,157 - $86,622	-64,165 Reduced 59.43%	43,795 $22,000
Q4 2023 Feb 14, 2024	SELL	$1.32 - $4.83 $90,760 - $332,101	-68,758 Reduced 38.91%	107,960 $148,000
Q3 2023 Nov 15, 2023	BUY	$3.02 - $4.05 $383,582 - $514,406	127,014 Added 255.54%	176,718 $537,000
Q2 2023 Aug 14, 2023	SELL	$2.79 - $5.03 $765,288 - $1.38 Million	-274,297 Reduced 84.66%	49,704 $163,000
Q1 2023 May 15, 2023	SELL	$3.14 - $8.22 $225,772 - $591,034	-71,902 Reduced 18.16%	324,001 $1.03 Million
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $1.39 Million - $2.05 Million	241,725 Added 156.78%	395,903 $2.74 Million
Q3 2022 Nov 14, 2022	SELL	$3.75 - $7.39 $81,168 - $159,956	-21,645 Reduced 12.31%	154,178 $976,000
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $3,451 - $6,140	1,174 Added 0.67%	175,823 $728,000
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $710,821 - $1.85 Million	174,649 New	174,649 $847,000
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $1.34 Million - $2.5 Million	-118,939 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $1.18 Million - $1.44 Million	-65,161 Reduced 35.39%	118,939 $3.8 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $2.05 Million - $4.19 Million	123,652 Added 204.56%	184,100 $5.55 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $963,352 - $1.33 Million	35,031 Added 137.83%	60,448 $2.62 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $133,489 - $169,575	-3,876 Reduced 13.23%	25,417 $1.37 Million
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $794,426 - $1.35 Million	29,293 New	29,293 $1.79 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $32.4M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account